RA Capital Management »

Artiva Biotherapeutics shares owned by RA Capital Management

Quarter-by-quarter ownership of Artiva Biotherapeutics shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $152M 9.9M 15.45

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Janux Therapeutics SH (JANX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Tyra Biosciences SH (TYRA)
Evolent Health Inc - A SH (EVH)
Edgewise Therapeutics SH (EWTX)
Biogen SH (BIIB)
Dyne Therapeutics SH (DYN)
Rxsight SH (RXST)
Bicara Therapeutics SH
Climb Bio SH (ELYM)
Ars Pharmaceuticals SH (SPRY)

View all positions for RA Capital Management

Top funds holding Artiva Biotherapeutics

RA Capital Management
5AM Venture Management
VR Adviser
venBio Partners
Capital World Investors
BlackRock
Franklin Resources
Geode Capital Management
Samsara BioCapital
Woodline Partners
Northern Trust
Citadel Advisors
Alyeska Investment Group
Charles Schwab Investment Management
Bank of New York Mellon

View all funds holding Artiva Biotherapeutics